AAAAAA

   
Results: 1-17 |
Results: 17
The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity
Authors: Lycke, N Schon, K
Citation: N. Lycke et K. Schon, The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity, VACCINE, 19(17-19), 2001, pp. 2542-2548
CTA1-DD-Immune stimulating complexes: A novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen
Authors: Mowat, AMI Donachie, AM Jagewall, S Schon, K Lowenadler, B Dalsgaard, K Kaastrup, P Lycke, N
Citation: Ami. Mowat et al., CTA1-DD-Immune stimulating complexes: A novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen, J IMMUNOL, 167(6), 2001, pp. 3398-3405
Joining chain-expressing and -nonexpressing B cell populations in the mouse
Authors: Erlandsson, L Akerblad, P Vingsbo-Lundberg, C Kallberg, E Lycke, N Leanderson, T
Citation: L. Erlandsson et al., Joining chain-expressing and -nonexpressing B cell populations in the mouse, J EXP MED, 194(5), 2001, pp. 557-570
Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells
Authors: Johansson, M Lycke, N
Citation: M. Johansson et N. Lycke, Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells, IMMUNOLOGY, 102(2), 2001, pp. 199-208
Delayed type hypersensitivity-associated cytokines in islet xenotransplantation: limited efficacy of interleukin-2-and tumor necrosis factor-alpha-blockade in interferon-gamma receptor-deficient mice
Authors: Benda, B Lycke, N Holstad, M Korsgren, O
Citation: B. Benda et al., Delayed type hypersensitivity-associated cytokines in islet xenotransplantation: limited efficacy of interleukin-2-and tumor necrosis factor-alpha-blockade in interferon-gamma receptor-deficient mice, XENOTRANSPL, 7(3), 2000, pp. 206-213
Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation
Authors: Kurlberg, G Haglind, E Schon, K Tornqvist, H Lycke, N
Citation: G. Kurlberg et al., Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation, SC J IMMUN, 51(3), 2000, pp. 224-230
Dear friends of the Scandinavian Journal of Immunology
Authors: Moller, G Jonsson, R Natvig, JB Lycke, N Vartdal, F
Citation: G. Moller et al., Dear friends of the Scandinavian Journal of Immunology, SC J IMMUN, 51(1), 2000, pp. 1-1
The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic bcl-2-and germinal center-promoting effects
Authors: Agren, L Sverremark, E Ekman, L Schon, K Lowenadler, B Fernandez, C Lycke, N
Citation: L. Agren et al., The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic bcl-2-and germinal center-promoting effects, J IMMUNOL, 164(12), 2000, pp. 6276-6286
Expanding our knowledge in mucosal immunology
Authors: Lycke, N
Citation: N. Lycke, Expanding our knowledge in mucosal immunology, IMMUNOLOGIS, 7(1-2), 1999, pp. 35-38
Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD
Authors: Agren, L Norin, M Lycke, N Lowenadler, B
Citation: L. Agren et al., Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD, PROTEIN ENG, 12(2), 1999, pp. 173-178
Oral vaccination with immune stimulating complexes
Authors: Mowat, AM Smith, RE Donachie, AM Furrie, E Grdic, D Lycke, N
Citation: Am. Mowat et al., Oral vaccination with immune stimulating complexes, IMMUNOL LET, 65(1-2), 1999, pp. 133-140
Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection
Authors: Lycke, N Erlandsson, L Ekman, L Schon, K Leanderson, T
Citation: N. Lycke et al., Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection, J IMMUNOL, 163(2), 1999, pp. 913-919
MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
Authors: Simmons, CP Mastroeni, P Fowler, R Ghaem-maghami, M Lycke, N Pizza, M Rappuoli, R Dougan, G
Citation: Cp. Simmons et al., MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants, J IMMUNOL, 163(12), 1999, pp. 6502-6510
Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses
Authors: Smith, RE Donachie, AM Grdic, D Lycke, N Mowat, AM
Citation: Re. Smith et al., Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses, J IMMUNOL, 162(9), 1999, pp. 5536-5546
Surface and gene expression of immunoglobulin E receptors on mast cells and mast-cell numbers in interleukin-4-gene knockout mice
Authors: Chen, XJ Lycke, N Enerback, L
Citation: Xj. Chen et al., Surface and gene expression of immunoglobulin E receptors on mast cells and mast-cell numbers in interleukin-4-gene knockout mice, IMMUNOLOGY, 96(4), 1999, pp. 544-550
Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental African trypanosomiasis
Authors: Hamadien, M Lycke, N Bakhiet, M
Citation: M. Hamadien et al., Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental African trypanosomiasis, IMMUNOLOGY, 96(4), 1999, pp. 606-611
The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action
Authors: Grdic, D Smith, R Donachie, A Kjerrulf, M Hornquist, E Mowat, A Lycke, N
Citation: D. Grdic et al., The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action, EUR J IMMUN, 29(6), 1999, pp. 1774-1784
Risultati: 1-17 |